NO20020213L - Svovelsyre mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin- 4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester - Google Patents
Svovelsyre mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin- 4-yl}-hydroxy-methyl)-2-methoxy-phenyl]esterInfo
- Publication number
- NO20020213L NO20020213L NO20020213A NO20020213A NO20020213L NO 20020213 L NO20020213 L NO 20020213L NO 20020213 A NO20020213 A NO 20020213A NO 20020213 A NO20020213 A NO 20020213A NO 20020213 L NO20020213 L NO 20020213L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- piperidin
- fluoro
- methoxy
- hydroxy
- Prior art date
Links
- CFCNFOWLAPIQEJ-UHFFFAOYSA-N [3-[[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]-hydroxymethyl]-2-methoxyphenyl] hydrogen sulfate Chemical compound COC1=C(OS(O)(=O)=O)C=CC=C1C(O)C1CCN(CCC=2C=CC(F)=CC=2)CC1 CFCNFOWLAPIQEJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35470499A | 1999-07-16 | 1999-07-16 | |
| PCT/US2000/019065 WO2001005764A2 (en) | 1999-07-16 | 2000-07-13 | Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20020213D0 NO20020213D0 (no) | 2002-01-15 |
| NO20020213L true NO20020213L (no) | 2002-02-22 |
| NO324177B1 NO324177B1 (no) | 2007-09-03 |
Family
ID=23394565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020213A NO324177B1 (no) | 1999-07-16 | 2002-01-15 | Svovelsyremono-[3-({1-[2-(4-fluor-fenyl)-etyl]-piperidin-4-YL}-hydroxy-metyl)-2-metoksy-fenyl]ester, fremgangsmate for fremstilling derav samt mellomprodukt, fremgangsmate for a isolere forbindelsen, anvendelse av forbindelsen samt farmasoytisk sammensetning |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1202967B1 (no) |
| JP (1) | JP2003505374A (no) |
| KR (1) | KR100737718B1 (no) |
| AR (1) | AR024762A1 (no) |
| AT (1) | ATE348807T1 (no) |
| AU (1) | AU769484B2 (no) |
| BR (1) | BR0012477A (no) |
| CA (1) | CA2374635C (no) |
| CY (1) | CY1107658T1 (no) |
| DE (1) | DE60032489T2 (no) |
| DK (1) | DK1202967T3 (no) |
| ES (1) | ES2276688T3 (no) |
| HU (1) | HUP0202297A3 (no) |
| IL (2) | IL147310A0 (no) |
| MX (1) | MXPA02000444A (no) |
| NO (1) | NO324177B1 (no) |
| NZ (1) | NZ516286A (no) |
| PL (1) | PL353749A1 (no) |
| PT (1) | PT1202967E (no) |
| WO (1) | WO2001005764A2 (no) |
| ZA (1) | ZA200200101B (no) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169096A (en) * | 1985-07-02 | 1992-12-08 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl-piperidine-methanol derivatives |
| KR100211713B1 (ko) * | 1990-06-01 | 1999-08-02 | 슈테펜 엘. 네스비트 | (+)-알파-(2,3-디메톡시페닐)-1-[2-(4-플루오로페닐)에틸]-4-피페리딘메탄올 |
| US5618824A (en) * | 1994-03-09 | 1997-04-08 | Merrell Pharmaceuticals Inc. | Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
-
2000
- 2000-07-13 DK DK00947304T patent/DK1202967T3/da active
- 2000-07-13 PL PL00353749A patent/PL353749A1/xx not_active Application Discontinuation
- 2000-07-13 IL IL14731000A patent/IL147310A0/xx active IP Right Grant
- 2000-07-13 WO PCT/US2000/019065 patent/WO2001005764A2/en not_active Ceased
- 2000-07-13 KR KR1020027000670A patent/KR100737718B1/ko not_active Expired - Fee Related
- 2000-07-13 DE DE60032489T patent/DE60032489T2/de not_active Expired - Fee Related
- 2000-07-13 ES ES00947304T patent/ES2276688T3/es not_active Expired - Lifetime
- 2000-07-13 EP EP00947304A patent/EP1202967B1/en not_active Expired - Lifetime
- 2000-07-13 CA CA002374635A patent/CA2374635C/en not_active Expired - Fee Related
- 2000-07-13 AU AU60939/00A patent/AU769484B2/en not_active Ceased
- 2000-07-13 AT AT00947304T patent/ATE348807T1/de not_active IP Right Cessation
- 2000-07-13 HU HU0202297A patent/HUP0202297A3/hu unknown
- 2000-07-13 MX MXPA02000444A patent/MXPA02000444A/es active IP Right Grant
- 2000-07-13 NZ NZ516286A patent/NZ516286A/xx unknown
- 2000-07-13 JP JP2001511425A patent/JP2003505374A/ja active Pending
- 2000-07-13 PT PT00947304T patent/PT1202967E/pt unknown
- 2000-07-13 BR BR0012477-0A patent/BR0012477A/pt not_active Application Discontinuation
- 2000-07-17 AR ARP000103646A patent/AR024762A1/es not_active Application Discontinuation
-
2001
- 2001-12-25 IL IL147310A patent/IL147310A/en not_active IP Right Cessation
-
2002
- 2002-01-04 ZA ZA200200101A patent/ZA200200101B/xx unknown
- 2002-01-15 NO NO20020213A patent/NO324177B1/no not_active IP Right Cessation
-
2007
- 2007-02-13 CY CY20071100192T patent/CY1107658T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1107658T1 (el) | 2013-04-18 |
| EP1202967B1 (en) | 2006-12-20 |
| EP1202967A2 (en) | 2002-05-08 |
| HUP0202297A2 (en) | 2002-10-28 |
| PT1202967E (pt) | 2007-02-28 |
| MXPA02000444A (es) | 2002-07-02 |
| ZA200200101B (en) | 2003-06-25 |
| WO2001005764A2 (en) | 2001-01-25 |
| AU6093900A (en) | 2001-02-05 |
| NO20020213D0 (no) | 2002-01-15 |
| NZ516286A (en) | 2004-03-26 |
| DK1202967T3 (da) | 2007-04-10 |
| CA2374635C (en) | 2007-04-17 |
| KR100737718B1 (ko) | 2007-07-11 |
| WO2001005764A3 (en) | 2001-10-04 |
| DE60032489D1 (de) | 2007-02-01 |
| CA2374635A1 (en) | 2001-01-25 |
| IL147310A (en) | 2007-10-31 |
| HUP0202297A3 (en) | 2010-01-28 |
| AR024762A1 (es) | 2002-10-23 |
| NO324177B1 (no) | 2007-09-03 |
| AU769484B2 (en) | 2004-01-29 |
| PL353749A1 (en) | 2003-12-01 |
| JP2003505374A (ja) | 2003-02-12 |
| BR0012477A (pt) | 2002-04-02 |
| ATE348807T1 (de) | 2007-01-15 |
| IL147310A0 (en) | 2002-08-14 |
| KR20020042619A (ko) | 2002-06-05 |
| ES2276688T3 (es) | 2007-07-01 |
| DE60032489T2 (de) | 2007-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60024345D1 (de) | Polymerelektrolyt | |
| ID22095A (id) | Asam aril-akrilat ester | |
| NO20006114L (no) | Nytt 3-aryl-2-hydroksypropionsyrederivat III | |
| EE200100708A (et) | Asendatud fenoksüäädikhapped | |
| DE60009108D1 (de) | Batteriedose | |
| ATE316093T1 (de) | Glucopyranosid-konjugate von 2-(4-hydroxy-phenyl)-1-(4-(2-amin-1-yl-ethoxy)- enzyl)-1h-indol-5-olen | |
| EP1158588A4 (en) | ELECTROCHEMICAL CONDENSER | |
| NO20020213L (no) | Svovelsyre mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin- 4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester | |
| ID26146A (id) | Proses untuk cis-1-{2-[4-(6-metoksi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il]fenoksi]etil} pirolidin | |
| LT2000075A (lt) | Nauja 6-hidroksi-3(4-[2-(piperidin-1-il)-etoksi]fenoksi)-2-(4-metoksifenil)benzo[b]tiofeno hidrochlorido kristalinė forma | |
| ATE315025T1 (de) | Ethansulfonyl-piperidin-derivate | |
| LT2000076A (lt) | Nauja 6-hidroksi-3(4-[2-(piperidin-1-il)-etoksi]fenoksi)-2-(4-metoksifenil)benzo[b]tiofeno hidrochlorido kristalinė forma | |
| ATE525362T1 (de) | 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4- | |
| ID24964A (id) | Bentuk-bentuk baru psendopolimorf dari asam dihidroklorida 2-[2-[4-[bis (4-fluorofenil) metil]-1-piperazinil) etoksi asetat | |
| SI1202967T1 (sl) | Mono-(3-(1-(2-(4-fluoro-fenil)-etil)-piperidin-4-il)-hidroksi-metil)-2- metoksi-fenil)ester zveplove kisline | |
| FI19992215A7 (fi) | Kalanterointimenetelmä | |
| DK1202966T3 (da) | Piperidinalkoholer | |
| FI991093A7 (fi) | Yhteyksien hallintamenetelmä | |
| FR2797350B1 (fr) | Plaque d'electrode pour accumulateur | |
| FI19992633L (fi) | Paperin lujuuteen vaikuttavat koostumukset | |
| FI19992027L (fi) | Menetelmä seinäelementtien ja sokkelin rakentamiseksi | |
| FR2795387B1 (fr) | Caisse americaine hermetique | |
| UA34022A (uk) | Спосіб підвищення висоти прикусу | |
| SE9801991D0 (sv) | New 3-aryl-2-hydroxypropionic acid derivative II | |
| SE9900999D0 (sv) | Skarvlist/anslutningslist |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |